MarkDZimmermanMD

PubMed

• Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice?
  Zimmerman, M.,Walsh, E.,Friedman, M.,Boerescu, D. A.,Attiullah, N.> ;J Affect Disord. 2017 Sep 01
• Body mass index, depression, and suicidality: The role of self-esteem in bariatric surgery candidates.
  Yusufov M, Dalrymple K, Bernstein MH, Walsh E, Rosenstein L, Chelminski I, Zimmerman M> ;J Affect Disord. 2017-01-15
• Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?
  Zimmerman, M.,Walsh, E.,Chelminski, I.,Dalrymple, K.> ;J Affect Disord. 2017 Jan 15
• Clinically useful screen for borderline personality disorder in psychiatric out-patients.
  Zimmerman M, Multach MD, Dalrymple K, Chelminski I> ;Br J Psychiatry. 2016-12-01
• The FDA's failure to address the lack of generalisability of antidepressant efficacy trials in product labelling.
  Zimmerman, M.> ;Br J Psychiatry. 2016 Jun 03
• Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling.
  Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D> ;J Affect Disord. 2016-01-15
• Psychosocial morbidity associated with bipolar disorder and borderline personality disorder in psychiatric out-patients: comparative study.
  Zimmerman M, Ellison W, Morgan TA, Young D, Chelminski I, Dalrymple K> ;Br J Psychiatry. 2015-10-01
• Have Treatment Studies of Depression Become Even Less Generalizable?: A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Effica...
  Zimmerman, M.,Clark, H. L.,Multach, M. D.,Walsh, E.,Rosenstein, L. K.,Gazarian, D.> ;Mayo Clin. Proc.. 2015 Aug 16
• A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder.
  Zimmerman M, Chelminski I, Young D, Dalrymple K, Martinez JH> ;J Affect Disord. 2014-10-01
• Anxiety symptoms among remitted depressed outpatients: prevalence and association with quality of life and psychosocial functioning.
  D'Avanzato C, Martinez J, Attiullah N, Friedman M, Toba C, Boerescu DA, Zimmerman M> ;J Affect Disord. 2013-10-01
• Severity classification on the Hamilton Depression Rating Scale.
  Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K> ;J Affect Disord. 2013-09-05
• Should criteria be specified for depressive disorder not otherwise specified?
  Zimmerman M, Martinez JH, Dalrymple K, Chelminski I, Young D> ;J Affect Disord. 2013-05-01
• Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in...
  Zimmerman M, Martinez J, Attiullah N, Friedman M, Toba C, Boerescu DA> ;J Affect Disord. 2012-12-15
• Evaluation of evidence for the psychotic subtyping of post-traumatic stress disorder.
  Gaudiano BA, Zimmerman M> ;Br J Psychiatry. 2010-10-01
• Psychosocial impairment associated with bipolar II disorder.
  Ruggero CJ, Chelminski I, Young D, Zimmerman M> ;J Affect Disord. 2007-12-01
• Does comorbid Social Anxiety Disorder impact the clinical presentation of principal Major Depressive Disorder?
  Dalrymple KL, Zimmerman M> ;J Affect Disord. 2007-06-01
• Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis.
  Posternak MA, Zimmerman M> ;Br J Psychiatry. 2007-04-01
• The impact of gender, age and depressed state on patients' perspectives of remission.
  McGlinchey JB, Zimmerman M, A Posternak M, Friedman M, Attiullah N, Boerescu D> ;J Affect Disord. 2006-10-01
• Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.
  Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, Biggs MM, Shores-Wilson K, Shelton RC, Luther JF, Thomas B, Trivedi MH> ;J Affect Disord. 2005-07-01
• An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials.
  Zimmerman M, Chelminski I, Posternak M> ;J Affect Disord. 2004-05-01
• How accurate are patients in reporting their antidepressant treatment history?
  Posternak MA, Zimmerman M> ;J Affect Disord. 2003-07-01
• The effectiveness of switching antidepressants during remission: a case series of depressed patients who experienced intolerable side effects.
  Posternak MA, Zimmerman M> ;J Affect Disord. 2002-05-01
• Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients.
  McDermut W, Mattia J, Zimmerman M> ;J Affect Disord. 2001-08-01
• Major depression and personality disorder.
  Zimmerman M, Pfohl B, Coryell WH, Corenthal C, Stangl D> ;J Affect Disord. 1991-08-01
• Variability in the substance use disorder exclusion criterion in antidepressant efficacy trials.
  Zimmerman, M.,Clark, H. L.,Multach, M. D.,Walsh, E.,Rosenstein, L. K.,Gazarian, D.> ;J Affect Disord. 2016 Mar 24
• Join now to see all